Liverpool to host world flagship pharma conference

Liverpool to host world flagship pharma conference

More than 50 world-class speakers on the latest scientific breakthroughs and new approaches in drug discovery research are to gather at one of the sector’s major conferences in Liverpool this autumn.

The ELRIG (European Laboratory Research and Innovation Group) Drug Discovery conference, the UK’s largest free to attend event of its kind, takes place from the 13-14th October 2016 at the Arena & Convention Centre Liverpool.

It will bring together more than 1000 industry leaders from across the pharma, biotech, academia and vendor communities, with the University of Liverpool’s Professor Sir Munir Pirmohamed one of the main speakers at the flagship event, speaking on drug safety in drug development.

Dr Peter Simpson, director of the N8 Research Partnership, said: “I’m absolutely convinced that bringing the whole community of academia, SMEs and major companies together truly fosters innovation and collaboration.

“It is wonderful to be returning to Liverpool and ideal that this event is returning to the North, a region where Health Innovation is highlighted as a major economic capability. Great advancement will come from quality research insights, informal discussions, and networking, to the benefit the drug discovery and life science communities.

Steve Rees, chair of ELRIG and VP of Screening Sciences and Sample Management at AstraZeneca, said: “Typically attracting 1200 attendees, the Drug Discovery meeting provides a unique opportunity for scientists from academia, biotech, pharma and the vendor community to hear world leading speakers describe advances in target identification and preclinical drug discovery. 

“We are delighted to bring our 10th Anniversary meeting to Liverpool and look forward to welcoming scientists from the N8 Universities to the meeting.”